Explains the multi-phase process of clinical trials, emphasizing ethical considerations, regulatory oversight, and their crucial role in bringing new drugs like Keytruda to market, including the debate around dosage data.
Explains the multi-phase process of clinical trials, emphasizing ethical considerations, regulatory oversight, and their crucial role in bringing new drugs like Keytruda to market, including the debate around dosage data.
Evaluate Safety & Efficacy
Bridge Lab to Patient
Phase 1: Safety & Dosage
Phase 2: Efficacy & Side Effects
Phase 3: Confirmation & Comparison
Phase 4: Post-Market Surveillance
Institutional Review Boards (IRBs)
Informed Consent
Regulatory Bodies (CDSCO, FDA)
Cost of Drug Development
Dosing Data Debate (e.g., Keytruda)
Accelerated Approval Pathways
Evaluate Safety & Efficacy
Bridge Lab to Patient
Phase 1: Safety & Dosage
Phase 2: Efficacy & Side Effects
Phase 3: Confirmation & Comparison
Phase 4: Post-Market Surveillance
Institutional Review Boards (IRBs)
Informed Consent
Regulatory Bodies (CDSCO, FDA)
Cost of Drug Development
Dosing Data Debate (e.g., Keytruda)
Accelerated Approval Pathways
Involve multiple phases (Phase 1, Phase 2, Phase 3, Phase 4) to assess safety, dosage, and efficacy
Require informed consent from participants
Adhere to ethical principles such as beneficence, non-maleficence, and justice
Regulated by agencies like the Central Drugs Standard Control Organization (CDSCO) in India
Involve various stakeholders including researchers, sponsors, ethics committees, and participants
Data from clinical trials is used to support regulatory approvals for new treatments
Randomized controlled trials (RCTs) are considered the gold standard for evaluating interventions
Explains the multi-phase process of clinical trials, emphasizing ethical considerations, regulatory oversight, and their crucial role in bringing new drugs like Keytruda to market, including the debate around dosage data.
Clinical Trials
Illustrated in 1 real-world examples from Apr 2026 to Apr 2026
Involve multiple phases (Phase 1, Phase 2, Phase 3, Phase 4) to assess safety, dosage, and efficacy
Require informed consent from participants
Adhere to ethical principles such as beneficence, non-maleficence, and justice
Regulated by agencies like the Central Drugs Standard Control Organization (CDSCO) in India
Involve various stakeholders including researchers, sponsors, ethics committees, and participants
Data from clinical trials is used to support regulatory approvals for new treatments
Randomized controlled trials (RCTs) are considered the gold standard for evaluating interventions
Explains the multi-phase process of clinical trials, emphasizing ethical considerations, regulatory oversight, and their crucial role in bringing new drugs like Keytruda to market, including the debate around dosage data.
Clinical Trials
Illustrated in 1 real-world examples from Apr 2026 to Apr 2026